During the past decade, University Retina and Macula Associates, PC conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 4 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 4 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Retina and Macula Associates, PC" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Genentech, Inc." with 2 trials sponsored, "Gyroscope Therapeutics Limited" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Ionis Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Retina and Macula Associates, PC" #1 collaborator was "Novartis Pharmaceuticals" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University Retina and Macula Associates, PC" are "Diabetic Macular Edema" (5 trials), "Geographic Atrophy" (5 trials), "Macular Degeneration" (3 trials), "Dry Age-related Macular Degeneration" (2 trials) and "Macular Degeneration, Age-Related" (2 trials). Many other conditions were trialed in "University Retina and Macula Associates, PC" in a lesser frequency.

Most popular intervention types in "University Retina and Macula Associates, PC" are "Drug" (14 trials), "Other" (4 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (6 trials), "Sham Procedure" (5 trials), "Aflibercept" (2 trials), "Galegenimab" (2 trials) and "Abicipar Pegol" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Retina and Macula Associates, PC" are 16 trials for "All" genders.

Currently, there are NaN active trials in "University Retina and Macula Associates, PC". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in University Retina and Macula Associates, PC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Retina and Macula Associates, PC, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".